May 2025 FDA Recall Bromfenac Ophthalmic Solution 0.09% by Alembic Pharmaceuticals Limited
D-0447-2025 - Failed Impurities/Degradation Specifications

This Class II drug recall was voluntarily initiated by Alembic Pharmaceuticals Limited on May 7, 2025 for the product Bromfenac Ophthalmic Solution 0.09%. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0447-2025

Reason for Recall
Failed Impurities/Degradation Specifications
Initiated
05-07-2025
Reported
06-04-2025
Quantity
N/A

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Alembic Pharmaceuticals Limited
Bromfenac Ophthalmic Solution 0.09%, 1.7 mL bottle, Rx only, Sterile, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, Manufactured by Alembic Pharmaceuticals Limitied, Gujarat, India, Made in India, NDC 62332-508-17

Batch or Lot Expiration Information

Lot# Lot 7230309, Exp Date: 5/31/2025; Lot 7230310, Exp Date: 5/31/2025; Lot 7230311, Exp Date: 5/31/2025

Affected Packages Involved in this Recall